Sign In
Buy GTLL
$0.0002
+0 (+0%)
At Close: Jun 05, 2026
Global Energy Metals Provides Q1 2025 Progress Update on Portfolio Companies and Asset Holdings
08:30am, Thursday, 10'th Apr 2025
Vancouver, BC - TheNewswire - April 10, 2025 - Global Energy Metals Corporation ( TSXV:GEMC | OTCQB:GBLEF | FSE:5GE1 ) (“Global Energy Metals”, the “Company” and/or “GEMC”) , a multi-juris
Cognyte 2025 Threat Landscape Report Reveals Global Trends in Cyberattacks, Ransomware and Stolen Credentials
08:00am, Thursday, 10'th Apr 2025
HERZLIYA, Israel--(BUSINESS WIRE)--The Cognyte 2025 Threat Landscape Report reveals global trends in cyberattacks, ransomware and stolen credentials.
BOSTON--(BUSINESS WIRE)--State Street Global Advisors, the asset management business of State Street Corporation (NYSE: STT), today announced the launch of its State Street Target Retirement IndexPlus
NEW YORK CITY, NY / ACCESS Newswire / April 10, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Venture Global, Inc. ("Venture Global" or the "Company") (NYSE:VG). Su
Dragonfly Energy Wins the 2025 “Battery Technology Company of the Year” CleanTech Breakthrough Award
07:30am, Thursday, 10'th Apr 2025
Annual Awards Program Recognizes Companies and Products Driving Innovation in the Global Clean Technology Industry Annual Awards Program Recognizes Companies and Products Driving Innovation in the Glo
Paratek Pharmaceuticals to Present New Data on NUZYRA® (omadacycline) at ESCMID Global 2025
07:30am, Thursday, 10'th Apr 2025
BOSTON, April 10, 2025 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc., a privately held pharmaceutical company developing specialty therapies for community care and public health challenges, today
Venture Global, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - VG
07:30am, Thursday, 10'th Apr 2025
NEW YORK, NY / ACCESS Newswire / April 10, 2025 / If you suffered a loss on your Venture Global, Inc. (NYSE:VG) investment and want to learn about a potential recovery under the federal securities law
VG Shareholders Have Opportunity to Lead Venture Global, Inc. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today!
07:00am, Thursday, 10'th Apr 2025
NEW YORK CITY, NY / ACCESS Newswire / April 10, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Ventu
Faraday Future's Global President, Jerry Wang, Delivers Remarks at the Jones Technology and Innovation Conference Held in Las Vegas
01:07am, Thursday, 10'th Apr 2025
LAS VEGAS--(BUSINESS WIRE)--Faraday Future Intelligent Electric Inc. (Nasdaq: FFAI) ("FF", "Faraday Future", or the "Company"), a California-based global shared intelligent electric mobility ecosystem
Northern Trust Peer Study: A Look into the Evolving Priorities of Global Asset Owners
01:01am, Thursday, 10'th Apr 2025
CHICAGO & LONDON--(BUSINESS WIRE)-- #allocators--Northern Trust's report is based on a survey of 180 global asset owners, with investment portfolios ranging from US$1 billion to over US$500 billion.
VG LAWSUIT ALERT: Levi & Korsinsky Notifies Venture Global, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
11:15pm, Wednesday, 09'th Apr 2025
NEW YORK CITY, NY / ACCESS Newswire / April 9, 2025 / If you suffered a loss on your Venture Global, Inc. (NYSE:VG) investment and want to learn about a potential recovery under the federal securities
RADNOR, Pa., April 09, 2025 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed in the United
NEW YORK CITY, NY / ACCESS Newswire / April 9, 2025 / WHY: New York, N.Y., April 9, 2025.
Where Will Coinbase Global Stock Be in 1 Year?
06:14pm, Wednesday, 09'th Apr 2025
On Dec. 6, 2024, Coinbase's (COIN 16.93%) stock closed at $343.62 per share. That represented a 155% gain from the previous 12 months.
Global Generics Pharma Leader Selects Kneat
05:03pm, Wednesday, 09'th Apr 2025
Kneat's win of a global generics pharma leader showcases the versatility of its platform, which can be leveraged to deliver additional adjacent functions.
